Physician profile
Craig E Bowen
NPI 1396814091
$3,881.97
in general payments reported to CMS, 2019-2025
8 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Vision Therapy provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $9.44 · 2021: $31.19 · 2022: $16.49 · 2023: $2,787 · 2024: $518 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,278 · Food and Beverage: $1,201 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,278.01 |
| Food and Beverage | $1,201.43 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,720.54 | 2023 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Bausch & Lomb Americas INC. | $421.80 | 2022-2025 | Infuse |
| Visioneering Technologies, INC. | $250.00 | 2019 | |
| Lkc Technologies, INC. | $165.71 | 2024-2025 | |
| Coopervision INC. | $111.11 | 2021-2024 | Myday Contact Lens |
| Abbvie INC. | $109.27 | 2024 | |
| Maculogix, INC. | $84.85 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.